About BioCentra Diagnostics
BioCentra Diagnostics is a company based in Houston (United States) founded in 2008. BioCentra Diagnostics has raised $16.51 thousand across 1 funding round. BioCentra Diagnostics offers products and services including COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel. BioCentra Diagnostics operates in a competitive market with competitors including Prenetics, TScan Therapeutics, Karius, Day Zero Diagnostics and Brii Biosciences, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.51 K (USD)
in 1 rounds
-
Latest Funding Round
$16.51 K (USD), Seed
Aug 11, 2015
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioCentra Diagnostics
BioCentra Diagnostics offers a comprehensive portfolio of products and services, including COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel.
Detects COVID-19 virus with same-day results for travel needs.
Assesses drug-gene interactions for personalized medication choices.
Evaluates genetic risk for dementia and Alzheimer’s disease.
Identifies viruses and bacteria in respiratory infections.
Detects bacteria and fungi in urinary tract infections.
Funding Insights of BioCentra Diagnostics
BioCentra Diagnostics has successfully raised a total of $16.51K through 1 strategic funding round. The most recent funding activity was a Seed round of $16.51 thousand completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by BioCentra Diagnostics
Investment portfolio details for BioCentra Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioCentra Diagnostics
Detailed financials for BioCentra Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocentra Diagnostics Comparisons
Peer comparison for BioCentra Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioCentra Diagnostics
BioCentra Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, TScan Therapeutics, Karius, Day Zero Diagnostics and Brii Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of biologics to treat hepatitis B infection
|
|
| Locked | Locked | Locked |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
Detailed competitors of BioCentra Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocentra Diagnostics
Complete news archive for BioCentra Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioCentra Diagnostics
BioCentra Diagnostics was founded in 2008 and raised its 1st funding round 7 years after it was founded.
BioCentra Diagnostics is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
BioCentra Diagnostics is a funded company, having raised a total of $16.51K across 1 funding round to date.
BioCentra Diagnostics was established in 2008 in Houston, Texas, within the medical diagnostics sector. A range of laboratory testing services is offered, encompassing mens and womens wellness panels, allergy assessments, infectious disease screenings, and urinary tract infection pathogen panels. These operations are centered in the United States, supporting clinical diagnostics for various health conditions.
BioCentra Diagnostics's top competitors include Prenetics, GigaGen and Shattuck Labs.
BioCentra Diagnostics offers COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel.